Shares of UnitedHealth Group (UNH) rallied sharply on Thursday after a pair of bullish analyst notes reinforced growing optimism that the health insurer's turnaround is gaining momentum.
UnitedHealth stock climbed more than 5% in trading, helping lift the Dow Jones Industrial Average higher even as broader markets traded mixed.
The rally snapped a five-day losing streak and pushed the shares to around $396, extending their gain for the year to roughly 20%.
The move follows a difficult period for the healthcare giant.
In April 2025, UnitedHealth reported disappointing earnings and lowered its outlook, triggering a sharp selloff.
A month later, the company withdrew its guidance entirely and announced the resignation of Chief Executive Officer Andrew Witty, citing "personal reasons."
Bank of America upgrade boosts sentiment
The latest catalyst came from Bank of America, which upgraded UnitedHealth shares to Buy from Neutral and increased its price target to $450 from $420.
Analyst Kevin Fischbeck pointed to "improving medical cost trends and supportive near-term data points," which he believes create a "favorable" setup heading into the company's second-quarter earnings report.
The firm argued that recent operating trends suggest UnitedHealth's strong first-quarter performance was not simply the result of temporary factors.
According to the analysts, "incoming data points make it more difficult to believe that the strong Q1 was purely a function of weak flu and storms," potentially leaving additional upside for the stock.
Bank of America also expects UnitedHealth to outperform its own targets.
While the company is aiming for adjusted earnings of more than $18.25 per share in 2026, the brokerage raised its estimate to $18.70 from $18.60.
The analysts further argued that the company's earnings power stands roughly 50% above its previously stated 2026 outlook and that continued moderation in healthcare utilization trends could accelerate a return to target margins.
Morgan Stanley highlights AI opportunity
Morgan Stanley also added to the positive sentiment by raising its price target on UnitedHealth to $453 from $395 while maintaining an Overweight rating.
Analyst Erin Wright likewise cited signs of moderating utilization trends but also pointed to artificial intelligence as an additional earnings driver.
UnitedHealth plans to invest $1.5 billion in AI this year and has said it "conservatively" expects a two-to-one return on that investment.
The company has also been reshaping its operations through a broader strategic overhaul that has included reducing membership, selling the UK arm of its Optum healthcare delivery business, and increasing investments in technology.
Rally spreads across managed care sector
The positive analyst commentary helped lift the broader healthcare sector.
The State Street Health Care Select Sector SPDR (XLV) exchange-traded fund advanced 3.2%, putting it on pace for its largest single-day percentage gain in more than a year.
For investors, the latest upgrades suggest Wall Street is becoming increasingly confident that improving medical cost trends and operational changes could support a sustained recovery in UnitedHealth's earnings and share price.
Comments
Log in or sign up to join the conversation.